LabCorp
LabCorp
Content by LabCorp
|1 min read
Labcorp Expands Digital Pathology Rollout with FDA-Cleared PathAI Platform
Nationwide deployment of AISight® Dx aims to support fully digital workflows and AI-assisted diagnostics across anatomic pathology labs
|2 min read
Labcorp Brings Roche Automated Mass Spectrometry to US Clinical Laboratories
First US commercial agreement delivers next-generation technology for faster, more accurate diagnostics
|2 min read
Labcorp Expands MRD Testing for Breast, Lung, and Colon Cancer Recurrence Risk
Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer
|2 min read
Labcorp Expands STI Test Offerings with Rapid Syphilis Test
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the US, offering First to Know® Syphilis Test nationwide
|2 min read
FDA Approves Labcorp Cell-Based CDx for Hemophilia Gene Therapy, BEQVEZ
The companion diagnostic will help bring clarity to hemophilia B patients considering BEQVEZ as a treatment option
|2 min read
Labcorp Accelerates Molecular Residual Disease Research
The Plasma Detect™ is the first clinically validated, whole-genome sequencing MRD solution for early-stage colon cancerPage 1 of 1
